Involvement of the heart by small and medium vessel vasculitis

Current Opinion in Rheumatology

Volumn 21, Issue 1, 2009, Pages 29-34

  Kane, Garvan C ^a   Keogh, Karina A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac MRI; Churg strauss syndrome; Echocardiography; Heart; Wegener's granulomatosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ACUTE HEART INFARCTION; AORTITIS; CHURG STRAUSS SYNDROME; CONTRAST ENHANCEMENT; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART DISEASE; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM; HUMAN; IMAGE DISPLAY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS;

CHURG-STRAUSS SYNDROME; DIAGNOSTIC IMAGING; HEART; HEART VALVE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RHEUMATIC HEART DISEASE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 58149234933     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32831cb94d     Document Type: Review

References (30)

1. Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 2005; 14:718-722.
2. Keogh KA. Leukotriene receptor antagonists and Churg-Strauss syndrome: cause, trigger or merely an association? Drug Saf 2007; 30: 837-843.
3. Keogh KA, Specks U. Churg-Strauss syndrome: clinical presentation, antineutrophilic cytoplasmic antibodies and leukotriene receptor antagonists. Am J Med 2003; 115:284-290.
4. Val-Bernal JF, Mayorga M, Garcia-Alberdi E, ef a/. Churg-Strauss syndrome and sudden cardiac death. Cardiovasc Pathol 2003; 12:94-97.
5. Lie JT, Bayardo PJ. Isolated eosinophilic coronary arteritis and eosinophilic myocarditis. A limited form of Churg-Strauss syndrome. Arch Pathol Lab Med 1989; 113:199-201.
6. Ramakrishna G, Connolly HM, Tazelaar HD, et al. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis. Mayo Clin Proc 2000; 75:631 -635.
7. Oliveira GHM, Seward JB, Tsang TSM, et a/. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc 2005; 80:1435- 1440.
8. Eisen A, Arnson Y, Dovrish Z, ef al. Arrhythmias and conduction defects in • rheumatological diseases: a comprehensive review. Semin Arthritis Rheum 2008 [Epub ahead of print]. A review of cardiac rhythm disorders in vasculitis.
9. Sumitomo N, Karasawa K, Taniguchi K, Ichikawa R, et al. Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J 2008; 72:274-280.
10. Wood LE, Tulloh RM. Kawasaki Disease in children. Heart 2008 [Epub ahead •• of print]. A comprehensive contemporary review of Kawasaki disease.
11. Bongartz T, Matteson EL. Large-vessel vasculitis involvement in giant cell arteritis. Curr Opin Rheumatol 2006; 18:10-17.
12. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large vessel vasculitis: an update. Rheumatology (Oxford) 2008; 47:403-408.
13. Merkel PA, Lo GH, Holbrook JT, et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) study. Ann Intern Med 2005; 142:620-626.
14. Garcia G, Achouh L, Cobarzan D, et al. Severe venous thromboembolic disease in Churg-Strauss syndrome. Allergy 2005; 60:409-410.
15. Takeuchi D, Saji T, Takatsuki S, et al. Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 2007; 71:357-362.
16. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with13N-NH3/18F-FDG PET. J Nucl Med 2003; 44:1030-1036.
17. Morita H, Yokoyama I, Yamada N, et al. Usefulness of 18FDG/13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging 2004; 31:1218.
18. Brihaye B, Aouba A, Pagnoux C, et al. Rituximab reversed cardiac involvement • of Wegener's granulomatosis: magnetic resonance imaging assessment. Presse Med 2008; 37:412-415. The first case report describing either the use of cardiac MRI or rituximab therapy in Wegener's granulomatosis of the heart.
19. Vogel-Claussen J, Rochitte CE, Wu KC, et al. Delayed enhancement MR imaging: utility in myocardial assessment. Radiographics 2006; 26:795- 810.
20. Bohl S, Wassmuth R, Abdel-Aty H, et al. Delayed enhancement cardiac •• magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of nonischemic heart disease. Int J Cardiovasc Imaging 2008; 24:597-607. A comprehensive discussion of delayed MRI contrast enhancement in various disorders including vasculitis.
21. Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki Disease. Pediatr Int 2000; 42:241 - 248.
22. Yagci R, Totan Y, Ozluk E, et al. Serum levels of natriuretic peptides in patients with Behcet's disease. Clin Rheumatol 2008; 27:1153- 1158.
23. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52:2926-2935.
24. Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophilic cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum Dis 2008; 67:1004-1010.
25. Keogh KA, Wylam ME, Stone JH, et al. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophilic cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 262-268.
26. Keogh KA, Ytterberg SR, Fervenza FC, et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006; 173:180-187.
27. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine 1996; 75:17-28.
28. Solomon DH, Karison EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107:1303-1307.
29. Koening CL, Langford CA. Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am 2006; 32:173-186.
30. Rammer AJ, Sudano I, Hermann F, et al. Angiotensin-converting enzyme •• inhibition improves vascular function in rheumatoid arthritis. Circulation 2008; 117:2262-2269. This study introduces a therapy that improves the endothelial dysfunction related to rheumatoid arthritis-related inflammation.